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,\bstract The effects of a K’ channel blocker, bisG10, were 
examined on ATP-sensitive K+ (KATP) channels in membrane 
patches excised from mammalian and amphibian skeletal muscle 
libres using the patch-clamp technique. At micromolar concentra- 
tions, bisG10, added on the intracellular side, induced a strong, 
reversible, tllckery block of KArP channels. BisGlO, added on the 
extracellular side, was about lOO-fold less potent at inhibiting 
channel activity. At 10 nM, intracellular bisGl0 increased K,, 
channel activity. This activation was independent of the presence 
of internal ATP or Mg’+. The inhibitory effect of bisGl0 most 
lrkely arose from open-channel block whereas activation could 
result from more complex, indirect interactions. 
depending on the concentrations used. It blocks the channels 
at micromolar concentrations while it activates them at nano- 
molar concentrations. 
2. Materials and methods 
Methods were essentially the same as in previous works [4,10]. Using 
the patch-clamp technique, currents through K,, channels were re- 
corded in cell-free patches from, either enzymatically dissociated fibres 
from the flexor digitorum brevis and interosseal muscles of the adult 
mouse or sarcolemmal blebs elicited by mechanical cleavage of fibres 
dissected from the iliofibularis thigh muscle of the adult frog, Runa 
esculenta. Animals were killed by decapitation. 
j:ey words: l,lO-Bis-guanidino-n-decane; 
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: . Introduction 
ATP-sensitive potassium channels (KArP) are present at high 
t ensity in skeletal muscle sarcolemma. It is thought that K,, 
channels, inactive in resting muscle, open during fatigue to 
T educe excitability and lead muscle to rest [l]. However, there 
I xists yet no direct experimental evidence establishing this 
; ihysiological role. Pharmacological tools have been widely 
: sed to study the physiological function as well as the molecular 
~rechanisms of regulation of skeletal muscle KArP channels. 
!ulfonylureas, such as glibenclamide, are considered specific 
)Jockers of K,, channels [2,3]. Previous studies have shown 
I hat glibenclamide, at micromolar concentrations, produces 
I omplete inhibition of skeletal muscle K,, channels [4,5]. Clas- 
b ical channel blockers such as TEA or 4-AP are weak inhibitors 
, <f K,, channels that work only in the millimolar range [6,7]. 
Inside/out and outside/out patches were held at 0 mV throughout in 
solutions designed to approximate physiological ionic gradients. The 
cytoplasmic face of the patch was exposed to internal solutions contain- 
ine in mM: 145 K’. 140 Cl-. 1 EGTA. 10 HEPES. and 1 Me” extent 
where noted (pH 7.4) for mouse muscle and 150 K’, 40 C1-,cl EGTA, 
10 PIPES, and methanesulfonate- as the remaining anions (pH 7.1) for 
frog muscle. The extracellular face of the patch was exposed to external 
solutions containing in mM: 5 K’, 145 Na’, 152 Cl, 1 Mg’+, 2.5 Ca2’. 
and 10 HEPES (pH 7.4) for mouse muscle and 10 K’, 120 Na’, 126 Cl-, 
1 Mg’+, 2 Ca”, and 5 PIPES (pH 7.1) for frog muscle. ATP (potassium 
salt), ghbenclamide (100 mM stock in dimethyl sulfoxyde), and bisGl0 
(1 or 2 mM stock in bath solution) were added to the bathing solution 
as indicated. For mouse muscle experiments, the membrane patch was 
exposed to the various solutions by placing the patch in the mouth of 
a single perfusion tube connected by valves to a number of reservoirs. 
For frog muscle experiments, solutions were changed by means of a 
rapid ‘sewer pipes’ device. The lower exchange speed of the former 
method explains the apparently slower response times of mouse K,, 
channels. 
BisG 10 (1, IO-bis-guanidino-n-decane HSO,) was prepared from 2- 
methyl-2-thiopseudourea sulfate and 1, lo-diaminodecane (yield: 40%) 
as described by Garcia and Miller [9]. The chemical structure is: 
H HN __ 
HJy NAAMA II 
Jj A NH, HS.0, 
A diverse family of organic compounds known as K’ channel 
I jpeners activate K,, channels. In skeletal muscle, these agents 
‘ ct at concentrations between 1 and 100 ,uM. Depending on 
! heir chemical structure, some of them activate the channel only 
17 the presence of internal nucleotides while others increase 
1. hannel activity in their absence [.5,8]. 
In this paper, we investigate the effects on skeletal muscle 
r 
tik H 
+lATp channels of 1 ,lO-bis-guanidino-n-decane (bisG lo), a drug 
/ eported to inhibit sarcoplasmic reticulum (SR) K’ channels 
N]. We find that bisG10 has opposite effects on K,, channels 
The isolated pure bisG 10. H,S04 gave satisfactory analytical data: IR 
(KBr) cm-r: 3300, 3150, 3050, 1680, 1630, 1120, 1070. “C NMR 
(DzO + eCF,CO,D), 75 MHz, 6 in ppm relative to tetramethylsilane: 
27.8(-CH,-1. 29.8(-CH,-). 30.3(-CH,-). 30.5(-CH,-1. 43.0(-CH,- 
NH-). 1585(HN~C(NH$-NH-). ANAL. talc. fo; &HXo ‘N,O,S: 
C% = 40.66, H% = 8.53, S% = 9.05, found: C% = 40.87, H% = 8.60, 
SW = 8.86. 
3. Results 
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3.1. High-afjnity blockade of mouse skeletal muscle KATp 
channels by intracellular bisGl0 
Abbreviations; bisG10, 1, lo-bis-guanidino-n-decane; K,,, ATP-sensi- Fig. 1A describes the effects of bisG10 added to the cytoplas- 
I tve K’ channels. mic face in an inside/out membrane patch at 0 mV with a 
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Fig. 1. Intracellular bisGl0 potently blocks mouse skeletal muscle K,, 
channels in inside/out patches. (A) Effect of 1 PM, 10 ,uM bisGl0 and 
1 mM ATP on continuous recording of single K,, channel currents. 
BisGlO and ATP were added during the periods indicated by the bars. 
(B) Short segments of the main current trace in control and in the 
presence of bisG10. Arrows indicate zero current level. (C) Dose- 
response relationship between channel activity and internal bisGl0 
concentrations. Values were normalized to the value obtained in the 
absence of the drug. Average values of these normalized values were 
plotted. Bars and numbers denote number ofmeasurements and S.E.M. 
value. Solid line represents the prediction from a bimolecular block 
model with K,,z = 370 nM. 
physiological K’ gradient. In the absence of ATP at the cyto- 
plasmic face, K,, channels open spontaneously. Upon addi- 
tion of increasing concentrations of bisG10 to the internal solu- 
tion, channel activity decreased in a dose-dependent fashion. 
Mean current was reduced to 22% and 2% of control by 1 PM 
bisG10 and 10 ,LLM bisGl0 respectively. Short segments of the 
main trace displayed on an expanded time scale show that 
gating of the channels was altered by 10 FM bisGl0 (Fig. 1B). 
At this concentration of blocker, channels opened and closed 
rapidly in a ‘flickery’ manner so that the open-channel current 
level could no longer be clearly resolved at our recording band- 
width (400 Hz). After removal of the drug, current did not 
return completely to its control value, reflecting more the run- 
down of K,, channels than the persistent action of the drug. 
Subsequent addition of 1 mM ATP abolished channel activity 
confirming that all channels present were ATP-sensitive. After 
application of ATP, activity increased somewhat above control 
as described in previous work [l 11. 
Similar protocols were employed to test the inhibitory effect 
of bisGI0 in a number of patches. The resulting data was used 
to quantify the relationship between channel activity and 
bisG10 concentration for concentrations above 30 nM (Fig. 
1C). In spite of the dispersion of the data points due to the 
patch-to-patch variability of the response to bisG10, this rela- 
tionship pointed to a bimolecular reaction with simple 1 : 1 
binding of the drug with half-maximal inhibition at about 370 
nM. 
3.2. Low-affinity blockade of mouse skeletal muscle KATp 
channels by extracellular bisGl0 
The effect of an external application of bisG10 was tested in 
outside/out membrane patches held at 0 mV. In that configura- 
tion, K,, channels were identified by their sensitivity to gliben- 
clamide. Fig. 2 shows that extracellular like intracellular bisG10 
is able to block K,, channels. In that patch, addition of 
bisG 10 at a concentration of 100 ,DM depressed channel activity 
by about 90%. Subsequent addition of 10 ,uM glibenclamide 
nearly blocked all channel activity. In several patches, 100 ,LLM 
bisGl0 and 1 mM bisGl0 reduced channel activity to 33 t 9% 
(n = 5) and 5 f 4% (n = 3) of control, respectively. These obser- 
vations indicate that the drug is about 100 times less active from 
the outside than from the inside. 
In these outside/out experiments, given the physiological 
ionic gradients, K’ currents through K,, channels were out- 
wardly directed at 0 mV. Under these conditions, the drug 
added to the external face of the membrane moved upstream 
in the K’ ion flow and one may ask whether this might be the 
reason for the lesser efficacy of the blocker in outside/out exper- 
iments. However, in 5 inside/out patches tested under symmet- 
rical K’ conditions, we observed that the block by bisG10 from 
the cytoplasmic side was always more efficient than the block 
bisGl0 glibenclamide 
Fig. 2. Extracellular bisGl0 weakly blocks mouse skeletal muscle K,, 
channels in outside/out patches. (A) Effect of 100 ,uM bisGl0 and 10 
,uM glibenclamide on K,, channel activity. BisGlO and glibenclamide 
were added during the periods indicated by the bars. 
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Tig. 3. Intracellular bisGl0 at low concentrations activates mouse skel- 
,tal muscle K,, channels in inside/out patches. (A) Effects of IO nM 
md 10 PM bisGl0 in the absence of internal ATP and in the presence 
)f 1 mM internal Mg*’ on continuous recording of single K,, channel 
urrents in the same inside-out patch. (B) Effect of 1 mM internal ATP 
m channel activity enhanced by 10 nM bisGl0 in the presence of 1 mM 
vlg’+. (C) Effect of 10 nM bisGl0 on K,, channel activity in the 
nesence of 100 PM internal ATP and 1 mM internal Mg2+. (D) Effect 
jf 10 nM bisGl0 on K,, channel activity in the absence of internal 
tig’+. The bars indicate the periods during which bisG10 and ATP were 
idded and Mg’+ removed. 
ram the external side whatever the direction of the current (not 
.hown). 
t.3. Low concentrations of intracellular hisGl0 activate mouse 
skeletal muscle KATp channels 
Unexpectedly, we found that bisGl0 behaved as an activator 
of Km channels when used in the nanomolar range. Activating 
and blocking actions of bisG10 are shown in the same inside/ 
out membrane patch in Fig. 3A. In this patch, addition of 
bisGl0 at a concentration of 10 nM induced a greater than 
two-fold enhancement of channel activity. The activating effect 
was completely reversible upon washout of the drug. Subse- 
quent addition of 1OpM bisGl0 completely suppressed channel 
activity. This effect was reversible. Finally, ATP abolished 
channel activity. 
On the basis of single-channel current amplitude as deter- 
mined by amplitude histograms, channels opened by bisGl0 
could not be distinguished from K,&,, channels active in control 
conditions. Furthermore the channels activated by bisGl0 were 
blocked by ATP as demonstrated in Fig. 3B. In that inside/out 
patch, channel activity which was low in control was clearly 
enhanced by 10 nM bisGl0. In the continued presence of 
bisGl0, addition of 1 mM ATP led to a complete inhibition of 
channel activity. All these effects were reversible. Activation by 
bisGl0 was seen at 10 nM in about 70% of the patches tested 
(18 out of 26 patches). In those patches, 10 nM bisGl0 en- 
hanced channel opening to 218 + 23% of control. At 30 nM 
bisGl0, out of 6 patches tested, activation was observed in 
3 patches, no effect in 1 patch and a slight inhibition in 2 
patches; at 100 nM bisGl0, out of 17’patches tested, activation 
was observed in 6 patches, no effect in 2 patches and inhibition 
A bisG10 
IOnM 7!JM - 
70 pM 
10lMATP 
B 
[bisGlO] (M) 
Fig. 4. Agonist/antagonist action of intracellular bisGl0 on frog skele- 
tal muscle K,, channels in inside/out patches. (A) Continuous record- 
ing of currents from a patch containing several K,, channels at differ- 
ent concentrations of bisGl0 in the presence of a partially inhibiting 
dose of ATP. Designated sections of the record are displayed below on 
an expanded time scale. (B) Mean responses to bisGl0 compiled from 
data obtained in 5 patches using the protocol of panel A. Symbols and 
bars represent mean and S.E.M. Solid line represents the prediction 
from a bimolecular block model with K,,Z = 250 nM. 
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in 9 patches. These results can be interpreted in terms of a 
variable degree of overlap of the activatory and inhibitory con- 
centration ranges of the drug in distinct patches. 
It has been reported that skeletal muscle K,, channels are 
regulated by internal nucleotide triphosphates and di- 
phosphates in a Mg*‘-dependent manner [4,1&12]. Moreover, 
K’ channel openers such as cromakalim or pinacidil are 
thought to interact with nucleotide binding sites of the channel 
[5,8]. In order to determine whether bisGl0 acts directly on the 
channel or via an interaction with nucleotide binding sites, we 
investigated the effects of activatory concentration of bisGl0 
both in the presence of ATP and in the absence of Mg*+ at the 
cytoplasmic face. 
Fig. 3C indicates that an increase in activity by 10 nM bisG10 
could still be obtained when channels were blocked by internal 
ATP. In this patch, channels which were inhibited by 100 PM 
ATP could be substantially and reversibly reactivated by 10 nM 
bisGl0. Similar effects were observed in 5 patches in the pres- 
ence of 100 ,uM internal ATP. Enhancement could not be quan- 
tified accurately in those conditions because control activity in 
ATP was too low. 
Fig. 3D shows that bisG10 activated K,, channels in the 
absence of internal Mg2+. As described in a previous work [l 11, 
when internal Mg2+ was removed, currents through mouse skel- 
etal muscle K,, channels increased due to a parallel enhance- 
ment of channel activity and single channel current amplitude. 
In the absence of internal Mg*+, 10 nM bisG10 augmented 
activity by 90%. This effect was reversible upon washout of the 
drug. Additional experiments indicated that in the absence of 
internal Mg2+, channel activity was increased to 166 _+ 12% of 
the control (n = 4). 
3.4. Concentration-dependent activation and blockade of frog 
skeletal muscle KATP channels by intracellular bisGl0 
In similar conditions, internal bisGl0 had very similar effects 
on K,r channels from amphibian and from mammalian skele- 
tal muscle as illustrated in Fig. 4. Application of micromolar 
doses of bisGl0 caused a profound inhibition of channel activ- 
ity with a change in gating characterized by a dramatic increase 
in the number of brief closings. Given the precision of the 
experimental data, the measured dissociation constant of 250 
nM for bisGl0 block of amphibian channels matched well the 
value of 370 nM obtained for mammalian channels. 
Application of 10 nM bisG10 in the presence of IO,LLM ATP 
(a dose which produces 50% inhibition in frog [13]) resulted on 
average in about a 50% increase in channel activity (Fig. 4B). 
A concentration of 100 nM bisG10 did not significantly affect 
channel activity. Activation was therefore less marked in frog 
muscle than in mouse muscle. It was also less reproducible 
because observed in only about half of the patches tested. 
4. Discussion 
Until now, the sulfonylurea drug glibenclamide has been 
considered the most potent inhibitor of K,, channels [l]. In 
excised patches from skeletal muscle, glibenclamide produces 
complete inhibition of K,, channels at micromolar concentra- 
tions [4,5]. The present work demonstrates that the guanidin- 
ium derivative bisG10, primarily known as a SR K’ channel 
blocker (Garcia and Miller, 1984), inhibits skeletal muscle KArp 
channels with an efficacy similar to that of glibenclamide. For 
internal bisG10, 50% block of single-channel activity requires 
about 300 nM while, for glibenclamide, this figure is about 200 
nM in mammalian [5] and amphibian [4] skeletal muscles. 
Besides K,, channels, bisG10 has been shown to block 3 
other types of channels: a sarcoplasmic reticulum K’ channel 
reincorporated in artificial lipid bilayers [9], the sarcoplasmic 
reticulum calcium release channel [14], and a K’ channel pres- 
ent in blebs extruded from contracted frog muscle fibres [15]. 
Reported bisGl0 dissociation constants for these 3 channels 
were respectively 50, 280, and 48 ,LLM. Therefore, bisG10 has 
a much higher affinity for K,, channels but cannot be consid- 
ered as specific. In particular bisGl0 block was taken by Wang 
and Best [15] as evidence that the K+ channels observed in 
membrane blebs were of SR origin in spite of differences be- 
tween these channels and Kf channels reconstituted from SR 
vesicles [ 161 and in spite of certain resemblances (conductance, 
inward rectification) between these channels and sarcolemmal 
K Arp channels. 
The drug bisG10 produced characteristic flickery block, i.e. 
rapid interruptions of the open-channel current. Similar flick- 
ery block of SR K’ channels was induced by bis-quaternary 
ammonium compounds with long carbon chains in planar bi- 
layers [17]. This flicker is thought to arise from the movement 
of blocking molecules into and out of the channel. The flickery 
block of K,, channels by bisG10 could thus reflect the pres- 
ence of a binding site located within the channel conduction 
pathway rather than a more remote allosteric site as seems to 
be the case for sulfonylureas. 
K,, channels were blocked asymmetrically by bisGl0. The 
drug was found to be about 100 times more potent internally 
than externally. Asymmetrical block of K’ permeation through 
reconstituted SR K’ channels by bisG10 and bis-quaternary 
ammonium compounds has also been described [9,17]. In that 
case, the drugs were more effective from the cis side of the 
planar bilayer, presumably the cytoplasmic side, than from the 
trans side. However, in excised patches from skinned muscle 
fibre of lobster, Tang, Wang and Eisenberg [18] found that 
block by bis-quaternary ammonium compounds of the SR K’ 
channel was more effective when the drug was added to the 
cytoplasmic side of the channel. The lower potency of bisGl0 
externally applied does not seem to entirely result from a ‘clear- 
ing’ of the drug by the outward K’ current since we observed 
that, whatever the K’ current direction, bisGl0 always blocked 
K ATP channels more effectively from the cytoplasmic side. It 
may be suggested that bisGl0, when added to the external face 
of the membrane, binds to a site different from the binding site 
accessible from the cytoplasmic side. 
At nanomolar concentrations, we found that bisG10 could 
produce significant increases in channel activity. On the basis 
of single-channel conductance and ATP sensitivity, the chan- 
nels activated by bisG10 were identified as K,, channels. Ac- 
tivation of skeletal muscle K ATp channels by low concentrations 
of bisGl0 is a striking result. To our knowledge, no other drug 
is capable of activating K,, channels from skeletal muscle or 
other tissues at nanomolar concentrations. K’ channel openers 
are usually effective at concentrations in the micromolar range 
with highest affinity in smooth muscle cells where cromakalim 
at concentrations of tens nanomolar induces relaxation via a 
postulated but controversial activation of K,, channels [ 1,191. 
The fact that the primary action of these agents is to activate 
channels closed by internal ATP has led to the hypothesis that 
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K’ channel openers reverse nucleotide inhibition via a compet- 
itive mechanism (e.g. [20]). That bisGl0 activates KATp chan- 
nels both in the absence and in the presence of internal ATP 
suggests that activatory action of bisGl0 does not involve inter- 
xtion with nucleotidic binding sites. This conclusion is 
s’trengthened by the fact that activation occurred both in the 
bsence and in the presence of internal Mg*+ which is known 
o modulate the effects of nucleotide triphosphates as well as 
urcleotide diphosphates on skeletal muscle K,, channels [ 1 O- 
21. 
The high affinity of bisGl0 for KATP channels makes this 
ompound a potentially valuable structural probe. Nonethe- 
ess, further work needs to be done in order to elucidate the 
nechanisms of the inhibitory and activatory actions of bisG10. 
nhibition, already studied in other channel types, is probably 
lue to open-channel block and therefore linked directly to the 
:hannel pore. However, activation by such a compound has not 
)een described before and could arise from a more indirect 
nteraction as suggested by our failure to observe that activa- 
ion in all cases. 
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